EMBECTA CORP. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
EMBECTA CORP. (EMBC) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$2.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-07
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$2.60M, a 110.40% decline year-over-year.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$5.60M, a 149.12% decline year-over-year.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $1.20M.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$3.50M, a 125.93% decline year-over-year.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $6.00M, a 63.19% decline from fiscal 2024.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $16.30M, a 3.16% increase from fiscal 2023.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $15.80M.
- EMBECTA CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$64.20M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.60M 10-Q · filed 2026-08-07 | -$8.20M derived: sum of 2 quarters · filed 2026-08-07 | -$7.00M 10-Q · filed 2026-08-07 | -$10.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$5.60M 10-Q · filed 2026-05-05 | -$4.40M 10-Q · filed 2026-05-05 | -$7.90M derived: sum of 3 quarters · filed 2026-05-05 | $17.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.20M 10-Q · filed 2026-02-05 | -$2.30M derived: sum of 2 quarters · filed 2026-02-05 | $22.70M derived: sum of 3 quarters · filed 2026-08-07 | $34.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $21.50M derived: sum of 2 quarters · filed 2026-08-07 | $32.90M derived: sum of 3 quarters · filed 2026-08-07 | $6.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $25.00M 10-Q · filed 2026-08-07 | $36.40M derived: sum of 2 quarters · filed 2026-08-07 | $9.50M 10-Q · filed 2026-08-07 | $23.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $11.40M 10-Q · filed 2026-05-05 | -$15.50M 10-Q · filed 2026-05-05 | -$2.00M derived: sum of 3 quarters · filed 2026-05-05 | -$8.40M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$26.90M 10-Q · filed 2026-02-05 | -$13.40M derived: sum of 2 quarters · filed 2026-02-05 | -$19.80M derived: sum of 3 quarters · filed 2026-02-05 | -$22.20M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $7.10M derived: sum of 2 quarters · filed 2025-11-25 | $4.70M derived: sum of 3 quarters · filed 2025-11-25 | $16.30M 10-K · filed 2025-11-25 |
| 2024-06-30 | -$6.40M 10-Q · filed 2025-08-08 | -$8.80M derived: sum of 2 quarters · filed 2025-08-08 | $2.80M 10-Q · filed 2025-08-08 | -$11.60M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | -$2.40M 10-Q · filed 2025-05-09 | $9.20M 10-Q · filed 2025-05-09 | -$5.20M derived: sum of 3 quarters · filed 2025-11-25 | -$3.70M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $11.60M 10-Q · filed 2025-02-06 | -$2.80M derived: sum of 2 quarters · filed 2025-11-25 | -$1.30M derived: sum of 3 quarters · filed 2025-11-25 | $1.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$12.90M derived: sum of 2 quarters · filed 2025-11-25 | -$10.20M derived: sum of 3 quarters · filed 2025-11-25 | $15.80M 10-K · filed 2025-11-25 |
| 2023-06-30 | $1.50M 10-Q · filed 2024-08-09 | $4.20M derived: sum of 2 quarters · filed 2024-08-09 | $30.20M 10-Q · filed 2024-08-09 | $3.30M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $2.70M 10-Q · filed 2024-05-09 | $28.70M 10-Q · filed 2024-05-09 | $1.80M derived: sum of 3 quarters · filed 2024-12-11 | -$19.60M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $26.00M 10-Q · filed 2024-02-09 | -$900.00K derived: sum of 2 quarters · filed 2024-12-11 | -$22.30M derived: sum of 3 quarters · filed 2024-12-11 | -$29.40M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | -$26.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | -$48.30M derived: sum of 2 quarters · filed 2024-12-11 | -$55.40M derived: sum of 3 quarters · filed 2024-12-11 | -$64.20M 10-K · filed 2024-12-11 |
| 2022-06-30 | -$21.40M 10-Q · filed 2023-08-08 | -$28.50M derived: sum of 2 quarters · filed 2023-08-08 | -$37.30M 10-Q · filed 2023-08-08 | -$42.50M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | -$7.10M 10-Q · filed 2023-05-12 | -$15.90M 10-Q · filed 2023-05-12 | -$21.10M derived: sum of 3 quarters · filed 2023-11-29 | -$21.10M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | -$8.80M 10-Q · filed 2023-02-14 | -$14.00M derived: sum of 2 quarters · filed 2023-11-29 | -$14.00M derived: sum of 3 quarters · filed 2023-11-29 | -$17.80M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | -$5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | -$5.20M derived: sum of 2 quarters · filed 2023-11-29 | -$9.00M derived: sum of 3 quarters · filed 2023-11-29 | -$8.90M 10-K · filed 2023-11-29 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | -$3.80M derived: sum of 2 quarters · filed 2022-08-15 | -$3.70M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | -$3.80M 10-Q · filed 2022-05-13 | -$3.70M 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $16.40M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |